+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay



Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay



Immunogenetics 26(3): 178-187



Mutagen treatment of mouse mastocytoma P815 produces highly immunogenic "tum-" variants. Most of these variants express potent transplantation antigens which are not present on the original P815 tumor cells. These tum- antigens, which appear to be specific for each variant, elicit a strong cytolytic T lymphocyte (CTL) response, but do not seem to induce a specific antibody response. As a first step in the isolation of the gene of a tum- antigen, we attempted DNA-mediated gene transfer. As a DNA recipient cell we used P1.HTR, a highly transfectable P815 cell line, whose selection has been previously described. For the detection of antigen-expressing cells in transfected populations we developed a procedure that relies on the ability of these cells to stimulate the proliferation of the relevant CTL. Using DNA from tum- variant P91 mixed with a plasmid carrying an antibiotic resistance gene, we obtained several independent transfectants expressing a tum- antigen, at a frequency of approximately 1 in 13,000 antibiotic-resistant transfectants. These transfectants express only one of the two tum- antigens that were identified on P91, suggesting that these tum- antigens correspond to different genes. We expect that the detection procedure described here will be suitable for the identification of transfectants for any gene that determines the expression of an antigen recognized by CTL.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040360320

Download citation: RISBibTeXText

PMID: 3114137


Related references

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. European Journal of Immunology 12(5): 406-412, 1982

Detection of stable p815 transfectants expressing a tum negative antigen with a cytolytic t cell stimulation assay. Anticancer Research 7(5 Part A): 882, 1987

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. European Journal of Immunology 12(5): 401-406, 1982

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids. Somatic Cell Genetics 9(3): 345-357, 1983

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. Journal of Experimental Medicine 152(5): 1175-1183, 1980

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. Ii. T lymphocyte-mediated cytolysis. Journal of Experimental Medicine 152(5): 1184-1193, 1980

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens. European Journal of Immunology 12(11): 905-908, 1982

Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815. European Journal of Cancer and Clinical Oncology 19(11): 1529-1537, 1983

Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes. European Journal of Cancer and Clinical Oncology 18(9): 867-874, 1982

Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815. European Journal of Immunology 15(11): 1111-1117, 1985

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 6. occasional escape from host rejection due to antigen loss secondary variants. International Journal of Cancer 31(1): 119-124, 1983

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. Journal of Experimental Medicine 157(3): 1040-1052, 1983

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. Proceedings of the National Academy of Sciences of the United States of America 85(7): 2274-2278, 1988

Immunogenic variants obtained by mutagenesis by mouse masto cytoma p 815 7. dominant expression of variant antigens in somatic cell hybrids. Somatic Cell Genetics 9(3): 345-358, 1983

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. Journal of Experimental Medicine 157(6): 1992-2001, 1983